M. Lindsay Grayson

7.5k total citations · 1 hit paper
95 papers, 4.9k citations indexed

About

M. Lindsay Grayson is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, M. Lindsay Grayson has authored 95 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 34 papers in Epidemiology and 20 papers in Pharmacology. Recurrent topics in M. Lindsay Grayson's work include Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Pneumonia and Respiratory Infections (12 papers). M. Lindsay Grayson is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Pneumonia and Respiratory Infections (12 papers). M. Lindsay Grayson collaborates with scholars based in Australia, United States and Switzerland. M. Lindsay Grayson's co-authors include Benjamin P. Howden, John Turnidge, George M. Eliopoulos, Patrick G. P. Charles, Jason A. Trubiano, Mary Jane Ferraro, Wendy Munckhof, Monica A. Slavin, Karin Thursky and Tony M. Korman and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and Journal of Bacteriology.

In The Last Decade

M. Lindsay Grayson

92 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations

2017 334 citations Julie Storr, Anthony Twyman et al. Antimicrobial Resistance and Infection Control profile →

Peers

M. Lindsay Grayson

EPIDE

PHARM

PHEOH

Albert Sotto France

Lennox K. Archibald United States

Silvano Esposito Italy

Anna S. Levin Brazil

Dilip Nathwani United Kingdom

E. Patchen Dellinger United States

Suzanne E. Geerlings Netherlands

Marco Falcone Italy

Ellie J. C. Goldstein United States

Alan D. Tice United States

Albert Sotto France

M. Lindsay Grayson

1.4k ×0.8

1.3k ×0.9

EPIDE

370 ×0.4

PHARM

644 ×1.0

PHEOH

530 ×0.8

Citations per year, relative to M. Lindsay Grayson M. Lindsay Grayson (= 1×) peers Albert Sotto

Countries citing papers authored by M. Lindsay Grayson

Since Specialization

Citations

This map shows the geographic impact of M. Lindsay Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lindsay Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lindsay Grayson more than expected).

Fields of papers citing papers by M. Lindsay Grayson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lindsay Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lindsay Grayson. The network helps show where M. Lindsay Grayson may publish in the future.

Co-authorship network of co-authors of M. Lindsay Grayson

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lindsay Grayson. A scholar is included among the top collaborators of M. Lindsay Grayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lindsay Grayson. M. Lindsay Grayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Devchand, Misha, Carl M. J. Kirkpatrick, Wendy Stevenson, et al.. (2019). Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. Journal of Antimicrobial Chemotherapy. 74(6). 1725–1730. 76 indexed citations

Devchand, Misha, Andrew J. Stewardson, Karen Urbancic, et al.. (2019). Outcomes of an electronic medical record (EMR)–driven intensive care unit (ICU)-antimicrobial stewardship (AMS) ward round: Assessing the “Five Moments of Antimicrobial Prescribing”. Infection Control and Hospital Epidemiology. 40(10). 1170–1175. 12 indexed citations

Zingg, Walter, Julie Storr, Benjamin J. Park, et al.. (2019). Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3). Antimicrobial Resistance and Infection Control. 8(1). 74–74. 8 indexed citations

Grayson, M. Lindsay. (2018). Kucers’ The use of Antibiotics. CRC Press eBooks. 11 indexed citations

Storr, Julie, Anthony Twyman, Walter Zingg, et al.. (2017). Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrobial Resistance and Infection Control. 6(1). 6–6. 334 indexed citations breakdown →

Trubiano, Jason A., Cosby A. Stone, M. Lindsay Grayson, et al.. (2017). The 3 Cs of Antibiotic Allergy—Classification, Cross-Reactivity, and Collaboration. The Journal of Allergy and Clinical Immunology In Practice. 5(6). 1532–1542. 66 indexed citations

Trubiano, Jason A., Caroline Chen, Allen Cheng, et al.. (2016). Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing: lessons for stewardship. Journal of Antimicrobial Chemotherapy. 71(6). 1715–1722. 105 indexed citations

Stewardson, Andrew J., et al.. (2014). Back to basics. Current Opinion in Infectious Diseases. 27(4). 379–389. 25 indexed citations

Spelman, Tim, Danny Liew, Trisha Peel, et al.. (2013). Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clinical Microbiology and Infection. 19(4). E181–E189. 112 indexed citations

10.

Gardiner, Bradley J., Andrew A. Mahony, Andrew G. Ellis, et al.. (2013). Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?. Clinical Infectious Diseases. 58(4). e101–e105. 85 indexed citations

11.

Mahony, Andrew A., Allen Cheng, Craig Aboltins, et al.. (2012). Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning. Influenza and Other Respiratory Viruses. 7(3). 403–409. 5 indexed citations

12.

Gardiner, Bradley J., M. Lindsay Grayson, & Gillian Wood. (2012). Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology. 45(2). 181–184. 12 indexed citations

13.

Osterhout, Gerard, Brandon Ellis, M. Lindsay Grayson, et al.. (2010). Use of the “RAM” susceptibility testing method for rapid detection of clarithromycin resistance in the Mycobacterium avium complex. Diagnostic Microbiology and Infectious Disease. 67(1). 47–51. 2 indexed citations

14.

Charles, Patrick G. P., Rory Wolfe, Michael Whitby, et al.. (2008). SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia. Clinical Infectious Diseases. 47(3). 375–384. 372 indexed citations

15.

Howden, Benjamin P., et al.. (2005). Low-level vancomycin resistance in Staphylococcus aureus?an Australian perspective. European Journal of Clinical Microbiology & Infectious Diseases. 24(2). 100–108. 15 indexed citations

16.

Grabsch, Elizabeth A., et al.. (2002). Bactericidal efficacy of sterilizing protocol for reused cardiac electrophysiology catheters. The American Journal of Cardiology. 89(6). 770–772. 7 indexed citations

17.

Wanke, C. A., et al.. (1999). Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand.. American Journal of Tropical Medicine and Hygiene. 60(5). 871–874. 16 indexed citations

18.

Stuart, Rhonda L., et al.. (1995). SAFETY OF IMIPENEM IN NEONATES. The Pediatric Infectious Disease Journal. 14(9). 804–804. 10 indexed citations

19.

Midolo, Peter, et al.. (1995). In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. Journal of Applied Bacteriology. 79(4). 475–479. 182 indexed citations

20.

Turnidge, John & M. Lindsay Grayson. (1993). Optimum Treatment of Staphylococcal Infections. Drugs. 45(3). 353–366. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact